This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The desirability of a safe and inexpensive medical treatment that can improve a patient's health and sense of well-being has resulted in the growing use of complementary and alternative medicine (CAM) worldwide. Once considered fringe medicine, meditation, yoga, and other mind-body therapies—the most commonly practiced form of CAM—are increasingly practiced by patients with chronic neurologic disorders, such as multiple sclerosis (MS).1 In a recent survey, up to 67% of patients with MS reported the current use of at least one form of CAM, with most regarding their practice as complementary rather than as an alternative to conventional medicine.2 Despite the popularity of CAM, there is a paucity of well-designed clinical trials evaluating its use in MS; most studies are hampered by small sample size or lack of a control arm.
The study by Grossman et al.3 in this issue of Neurology® was a randomized, single-blind, controlled trial that investigated the effects of mindfulness-based meditation compared to usual care on depression and quality of life measures in 150 patients with MS. Patients with remitting-relapsing and secondary progressive MS with an Expanded Disability Status …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.